Wes Chapman's Blog

The Website of M. Weston Chapman

  • Home
  • Medical
  • Economic Policy
  • Personal Interests
    • Kilimanjaro Climb
    • Staying in Motion with Arthritis
    • Prouty Prep Hikes
    • Highpointing
    • Hiking
    • Mountaineering
  • Chapman Strategy & Quality LLC
    • Bio
    • News
    • Services
    • Partners
  • Contact Wes
An analysis of FDA oncology drug approvals – implications for patients and clinical trials

An analysis of FDA oncology drug approvals – implications for patients and clinical trials

  • By Wes Chapman
  • August 25, 2019
  • 1 Comment

2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman August 18, 2019 Illustration of an [...]

Read more
Kilimanjaro – Prouty Mountaineering 2014

Kilimanjaro – Prouty Mountaineering 2014

  • By Wes Chapman
  • January 14, 2014
  • 7 Comments

          Mt. Kilimanjaro 19,341 Feet, 6 days ascent, 2 days descent The Prouty Mountaineering Program   January 12, 2014 Wes Chapman Preface: [...]

Read more

Welcome

For folks visiting on business, welcome, and I hope that you find this blog helpful. I have a passion regarding patient centered care – with a focus on outcome improvement and patient engagement. I’m a longtime fan of ISO 9001 and Lean/Six Sigma, and I hope that you find the material useful in making medicine safer and better. From a clinical perspective, I focus on oncology and how the practice of medical oncology is evolving to better serve patients. For folks visiting to read about mountains, bikes and economic policy – I hope you have as much fun reading as I do writing.

All the Best, Wes

Popular Posts

  • Making Sense of Documented Procedures in ISO 9001 – A Common Sense Guide for Hospitals Using NIAHO/ISO 9001
  • Using Corrective & Preventive Actions to Measure & Mitigate Risk
  • High Reliability Organizations (HROs) – Healthcare Considerations & Applications
  • EBITDA – The Oncology Valuation Series
  • CMS & ISO 9001 – The Impulse Toward Quality in Healthcare
  • Patient Reported Outcomes – Choosing Appropriate Metrics from a Still-Evolving Toolset
  • Medical Oncology Practice Valuation – Art & Science
  • Considering the Ebola Outbreak in Haddon’s Matrix and Reason’s Swiss Cheese Model
  • Perverse Incentives, Clumsy Laws, and the Value/Volume & RVU Conundrum in Medical Quality
  • The Opportunity of Oncology ACOs – Strategic Considerations & Challenges – A Return to the Elusive Promise of Capitation

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Wes Chapman's Blog

Copyright © 2020. Madidus Theme by CreativeKingdom & Different Themes